Imunon, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
Imunon, Inc. (IMNN) had Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number of 3.88 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber · last filed 2026-08-11
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 3.88M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 4.01M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 4.51M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 965.25K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number as first filed |
|---|---|---|
| 2026-06-30 | 3.88M shares 10-Q · filed 2026-08-11 | |
| 2026-03-31 | 4.01M shares 10-Q · filed 2026-05-12 | |
| 2025-12-31 | 4.51M shares 10-Q · filed 2026-08-11 | |
| 2025-09-30 | 965.25K shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 1.07M shares 10-Q · filed 2025-08-05 | |
| 2025-03-31 | 5.16M shares 10-Q · filed 2025-05-12 | |
| 2024-12-31 | 395.22K shares 10-K · filed 2026-03-31 | 5.16M shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 5.16M shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 160.06K shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 160.06K shares 10-Q · filed 2024-05-13 | |
| 2023-12-31 | 12.27K shares 10-K · filed 2026-03-31 | 160.06K shares 10-K · filed 2024-03-28 |
| 2023-09-30 | 160.06K shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 160.06K shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 164.46K shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 168.52K shares 10-K · filed 2025-02-27 | |
| 2022-09-30 | 168.52K shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 168.52K shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 168.52K shares 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 175.79K shares 10-K · filed 2024-03-28 | |
| 2021-09-30 | 2.64M shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 2.64M shares 10-Q · filed 2021-08-12 | |
| 2021-03-31 | 2.64M shares 10-Q · filed 2021-05-14 | |
| 2020-12-31 | 256.90K shares 10-K · filed 2023-03-30 | 3.85M shares 10-K · filed 2021-03-19 |
| 2020-09-30 | 4.05M shares 10-Q · filed 2020-11-16 | |
| 2020-06-30 | 3.83M shares 10-Q · filed 2020-08-14 | |
| 2020-03-31 | 3.83M shares 10-Q · filed 2020-05-15 | |
| 2019-12-31 | 41.74K shares 10-K · filed 2022-03-31 | 626.10K shares 10-K · filed 2020-03-25 |
| 2019-09-30 | 626.10K shares 10-Q · filed 2019-11-14 | |
| 2019-06-30 | 626.10K shares 10-Q · filed 2019-08-14 | |
| 2018-12-31 | 1.59M shares 10-K · filed 2021-03-19 | |
| 2018-09-30 | 3.25M shares 10-Q · filed 2018-11-14 | |
| 2018-06-30 | 3.25M shares 10-Q · filed 2018-08-14 | |
| 2017-12-31 | 3.06M shares 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |